Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Clariane SE's Enterprise Value is €8,737 Mil.
Clariane SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €315 Mil. Therefore, Clariane SE's EV-to-EBIT ratio for today is 27.74.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Clariane SE's Enterprise Value is €8,737 Mil.
Clariane SE's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €1,153 Mil. Therefore, Clariane SE's EV-to-EBITDA ratio for today is 7.58.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Clariane SE's Enterprise Value is €8,737 Mil.
Clariane SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €5,310 Mil. Therefore, Clariane SE's EV-to-Revenue ratio for today is 1.65.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Clariane SE's Enterprise Value is €8,737 Mil.
Clariane SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €816 Mil. Therefore, Clariane SE's EV-to-FCF ratio for today is 10.71.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Clariane SE (LTS:0OPS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Clariane SE's current Enterprise Value is €8,737 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €315 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Clariane SE's current Enterprise Value is €8,737 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €1,153 Mil.
Clariane SE's current Enterprise Value is €8,737 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €5,310 Mil.
Clariane SE's current Enterprise Value is €8,737 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €1,072 Mil.
Clariane SE's current Enterprise Value is €8,737 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €816 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE Enterprise Value Related Terms
Clariane SE Enterprise Value Historical Data
* Premium members only.
The historical data trend for Clariane SE's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0OPS vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Clariane SE's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Clariane SE's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Clariane SE's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (LTS:0OPS) has a Enterprise Value of €8,737 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Clariane SE and its competitors.
Is Clariane SE's Enterprise Value too high?
Clariane SE's current Enterprise Value is €8,737 Mil. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Enterprise Value compare to HCA and THC?
Clariane SE's Enterprise Value of €8,737 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Clariane SE and its competitors. Clariane SE's current Enterprise Value is €8,737 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.10 — trading 64.8% above its estimated fair value. The current Enterprise Value is €8,737 Mil. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current Enterprise Value is €8,737 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (LTS:0OPS) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.10 is trading 64.8% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for LTS:0OPS:
Enterprise Value: €8,737 Mil
GF Value™: €2.49 vs. price of €4.10 (64.8% above fair value)
No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for LTS:0OPS
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OPS has been successfully added to your 
